Published Year: 2023
Rare Disease Genetic Testing Market : Focus on Disease Type, Offering, Specialty Type, Sample Type,
The global rare disease genetic testing market was valued at $4.11 billion in 2022 and is...
Market Research Report
A quick peek into the report
Table of Contents
1.1 Market Outlook
1.1.1 Product Definition
1.1.2 Inclusion and Exclusion Criteria
1.1.2.1 Inclusion Criteria
1.1.2.2 Exclusion Criteria
1.1.3 Market Overview
1.1.3.1 Market Footprint
1.1.3.2 Market Size and Future Growth Potential
1.1.4 COVID-19 Impact on the Market
1.1.4.1 Impact on Research and Clinical Operations
1.1.4.2 COVID-19 Impact: Current Scenario of the Market
1.2 Industry Analysis
1.2.1 Regulatory Framework
1.2.1.1 Legal Requirements and Framework in the U.S.
1.2.1.2 Legal Requirements and Framework in Europe
1.2.1.2.1 U.K.
1.2.1.2.2 Spain
1.2.1.3 Legal Requirements and Framework in Asia-Pacific
1.2.1.3.1 Japan
1.2.1.3.2 China
1.2.1.3.3 India
1.2.1.3.4 Taiwan
1.2.2 Patent Analysis
1.2.2.1 Patent Filing Trend (by Country)
1.2.2.2 Patent Filing Trend (by Year)
1.2.3 Funding Scenario
1.3 Market Dynamics
1.3.1 Overview
1.3.2 Market Drivers
1.3.2.1 Rapid Technological Advancements in Rare Disease Diagnosis
1.3.2.2 Rising Prevalence of Genetic Disorders and Congenital Disorders
1.3.2.3 Growing Recognition and Emphasis on Early Detection and Prevention of Rare Diseases in Pediatric Populations
1.3.3 Market Challenges
1.3.3.1 Lack of Consolidation of Information Leading to Difficulty in Diagnosis
1.3.3.2 Significant Capital Requirement for Research and Development Hindering Global Expansion Efforts
1.3.4 Market Opportunities
1.3.4.1 Whole Genome Sequencing Putting an End to the Rare Disease Genetic Testing Odysseys
1.3.4.2 AI-Based Diagnostic Tools Diagnosing Rare Diseases by Identifying Potential Diagnoses
1.3.4.3 Transitioning toward Increased Genetics Coverage in Reimbursement Policies
2.1 Asia-Pacific Rare Disease Genetic Testing Market
2.1.1 Market Dynamics
2.1.1.1 Impact Analysis
2.1.2 Market Size and Forecast
2.1.2.1 Asia-Pacific Rare Disease Genetic Testing Market (by Disease Type)
2.1.2.2 Asia-Pacific Rare Disease Genetic Testing Market (by Technology)
2.1.2.3 Asia-Pacific Rare Disease Genetic Testing Market (by Country)
2.1.2.3.1 Japan
2.1.2.3.1.1 Market Dynamics
2.1.2.3.1.2 Market Size and Forecast
2.1.2.3.1.2.1 Japan Rare Disease Genetic Testing Market (by Disease Type)
2.1.2.3.1.2.2 Japan Rare Disease Genetic Testing Market (by Technology)
2.1.2.3.2 China
2.1.2.3.2.1 Market Dynamics
2.1.2.3.2.2 Market Size and Forecast
2.1.2.3.2.2.1 China Rare Disease Genetic Testing Market (by Disease Type)
2.1.2.3.2.2.2 China Rare Disease Genetic Testing Market (by Technology)
2.1.2.3.3 Australia
2.1.2.3.3.1 Market Dynamics
2.1.2.3.3.2 Market Size and Forecast
2.1.2.3.3.2.1 Australia Rare Disease Genetic Testing Market (by Disease Type)
2.1.2.3.3.2.2 Australia Rare Disease Genetic Testing Market (by Technology)
2.1.2.3.4 South Korea
2.1.2.3.4.1 Market Dynamics
2.1.2.3.4.2 Market Size and Forecast
2.1.2.3.4.2.1 South Korea Rare Disease Genetic Testing Market (by Disease Type)
2.1.2.3.4.2.2 South Korea Rare Disease Genetic Testing Market (by Technology)
2.1.2.3.5 India
2.1.2.3.5.1 Market Dynamics
2.1.2.3.5.2 Market Size and Forecast
2.1.2.3.5.2.1 India Rare Disease Genetic Testing Market (by Disease Type)
2.1.2.3.5.2.2 India Rare Disease Genetic Testing Market (by Technology)
2.1.2.3.6 Singapore
2.1.2.3.6.1 Market Dynamics
2.1.2.3.6.2 Market Size and Forecast
2.1.2.3.6.2.1 Singapore Rare Disease Genetic Testing Market (by Disease Type)
2.1.2.3.6.2.2 Singapore Rare Disease Genetic Testing Market (by Technology)
2.1.2.3.7 Rest-of-Asia-Pacific
2.1.2.3.7.1 Market Dynamics
2.1.2.3.7.2 Market Size and Forecast
2.1.2.3.7.2.1 Rest-of-Asia-Pacific Rare Disease Genetic Testing Market (by Disease Type)
2.1.2.3.7.2.2 Rest-of-Asia-Pacific Rare Disease Genetic Testing Market (by Technology)
3.1 Overview
3.1.1 3billion, Inc.
3.1.1.1 Company Overview
3.1.1.2 Role of 3billion, Inc. in the Rare Disease Genetic Testing Market
3.1.1.3 Recent Developments
3.1.1.4 Analyst Perspective
3.1.2 Konica Minolta (Ambry Genetics, Inc.)
3.1.2.1 Company Overview
3.1.2.2 Role of Konica Minolta (Ambry Genetics, Inc.) in the Rare Disease Genetic Testing Market
3.1.2.3 Financials
3.1.2.4 Recent Developments
3.1.2.5 Analyst Perspective
3.1.3 BGI Group
3.1.3.1 Company Overview
3.1.3.2 Role of BGI Group in the Rare Disease Genetic Testing Market
3.1.3.3 Financials
3.1.3.4 Recent Developments
3.1.3.5 Analyst Perspective
3.1.4 Strand Life Science Pvt Ltd.
3.1.4.1 Company Overview
3.1.4.2 Role of Strand Life Science Pvt Ltd. in the Rare Disease Genetic Testing Market
3.1.4.3 Recent Developments
3.1.4.4 Analyst Perspective
Table 1: Key Questions Answered in the Report
Table 2: Funding for Rare Disease Research
Table 3: Technological Advancements in the Rare Disease Genetic Testing Ecosystem
Table 4: Expansion of Medicare Coverage for Rare Disease Genetic Testing Tests (by Companies)
Table 5: Asia-Pacific Rare Disease Genetic Testing Market, Impact Analysis
Figure 1: Prevalence Rare Disease, 2022
Figure 2: Rare Disease Genetic Testing Market, $Billion, 2022-2033
Figure 3: Rare Disease Genetic Testing Market, Market Dynamics
Figure 4: Most Frequently Studied Rare Diseases, 2021
Figure 5: Rare Disease Genetic Testing Market Share (by Technology), 2022 and 2033
Figure 6: Rare Disease Genetic Testing Market Share (by Disease Type), 2022 and 2033
Figure 7: Rare Disease Genetic Testing Market (by Region), $Billion, 2022 and 2033
Figure 8: Share of Key Developments and Strategies, January 2019-June 2023
Figure 9: Rare Disease Genetic Testing Market: Research Methodology
Figure 10: Primary Research Methodology
Figure 11: Bottom-Up Approach (Segment-Wise Analysis)
Figure 12: Top-Down Approach (Segment-Wise Analysis)
Figure 13: Rare Disease Genetic Testing Market Potential, $Billion, 2022-2033
Figure 14: Regulatory Scenario in Europe (by Country)
Figure 15: Rare Disease Genetic Testing Market, Patent Analysis (by Country), January 2018- June 2023
Figure 16: Rare Disease Genetic Testing Market, Patent Analysis (by Year), January 2018-June 2023
Figure 17: NIH Funding on Rare Diseases, $Million, 2013-2023
Figure 18: Rare Disease Genetic Testing Market Dynamics
Figure 19: Rare Disease Prevalence in India, 2022
Figure 20: Prevalence of Rare Diseases, 2022
Figure 21: Most Frequently Studied Rare Diseases, 2021
Figure 22: Publications Related to the Use of Artificial Intelligence for Rare Disease Diagnosis, 2015-2022
Figure 23: Rare Disease Genetic Testing Market Share (by Region), 2022-2033
Figure 24: Asia-Pacific Rare Disease Genetic Testing Market, $Billion, 2022-2033
Figure 25: Asia-Pacific Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 26: Asia-Pacific Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 27: Asia-Pacific Rare Disease Genetic Testing Market (by Country), % Share, 2022 and 2033
Figure 28: Japan Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 29: Japan Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 30: Japan Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 31: China Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 32: China Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 33: China Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 34: Australia Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 35: Australia Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 36: Australia Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 37: South Korea Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 38: South Korea Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 39: South Korea Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 40: India Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 41: India Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 42: India Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 43: Singapore Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 44: Singapore Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 45: Singapore Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 46: Rest-of-Asia-Pacific Rare Disease Genetic Testing Market, $Million, 2022-2033
Figure 47: Rest-of-Asia-Pacific Rare Disease Genetic Testing Market (by Disease Type), $Million, 2022-2033
Figure 48: Rest-of-Asia-Pacific Rare Disease Genetic Testing Market (by Technology), $Million, 2022-2033
Figure 49: Rare Disease Genetic Testing Market, Total Number of Key Companies Profiled
Figure 50: 3billion, Inc: Product Portfolio
Figure 51: Konica Minolta (Ambry Genetics, Inc.): Product Portfolio
Figure 52: Konica Minolta (Ambry Genetics, Inc.).: Overall Financials, $Million, 2020-2022
Figure 53: Konica Minolta (Ambry Genetics, Inc.): Net Revenue (by Segment), $Million, 2020-2022
Figure 54: Konica Minolta (Ambry Genetics, Inc.): Net Revenue (by Region), $Million, 2020-2022
Figure 55: Konica Minolta (Ambry Genetics, Inc.): R&D Expenditure, $Million, 2020-2022
Figure 56: BGI Genomics: Product Portfolio
Figure 57: BGI Genomics.: Overall Financials, $Million, 2020-2022
Figure 58: Strand Life Science Pvt Ltd.: Product Portfolio
Asia-Pacific Rare Disease Genetic Testing Market Report Coverage
|
Asia-Pacific Rare Disease Genetic Testing Market |
|||
|
Base Year |
2022 |
Market Size in 2022 |
$0.51 Billion |
|
Forecast Period |
2023-2033 |
Value Projection and Estimation by 2033 |
$2.40 Billion |
|
CAGR During Forecast Period |
15.25% |
|
|
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analysing company coverage, product portfolio, and market penetration.
Some of the prominent names in this market are:
• 3billion, Inc.
• Konica Minolta (Ambry Genetics, Inc.)
• BGI Group
• Strand Life Science Pvt Ltd.
How can this report add value to an organization?
Product/Innovation Strategy: The Asia-Pacific rare disease genetic testing market has been extensively segmented on the basis of various categories, such as disease type, technology, and country. This can help readers understand which segments account for the largest share and which are well-positioned to grow in the coming years.
Competitive Strategy: The Asia-Pacific rare disease genetic testing market has numerous established players paving their way into providing tests, panels, and assays in the market. Key players in the Asia-Pacific rare disease genetic testing market analyzed and profiled in the study involve established players offering various disease-specific panels and multiplex instruments.
Introduction to Asia-Pacific Rare Disease Genetic Testing Market
The Asia-Pacific rare disease genetic testing market was valued at $0.51 billion in 2022 and is expected to reach $2.40 billion by 2033, witnessing a CAGR of 15.25% during the forecast period 2023-2033. Advanced technologies like whole-genome sequencing (WGS) and whole-exome sequencing (WES) examine a person's entire genetic code (genome) or certain sections that code for proteins (exome), respectively. These techniques aid in locating genetic defects, mutations, or variants that cause uncommon diseases.
Market Introduction
The growing need for early rare illness detection has led to a notable surge in the Asia-Pacific market for rare disease genetic testing. One of the main factors driving market expansion has been the rising incidence of uncommon diseases. Additionally, it is anticipated that the increasing awareness and focus on the early identification and prevention of rare diseases in pediatric populations globally would have an impact on market expansion.
Genetic testing for rare diseases offers enormous promise to provide cutting-edge medical treatments. For example, in January 2023, BGI Genomics created the ""CardioGen automated interpretation system,"" which functions as the genotype and phenotype database of monogenic cardiovascular disease. This system was developed in collaboration with the National Centre for Cardiovascular Diseases, Fuwai Hospital, and the State Key Laboratory of Cardiovascular Diseases. The market growth is also influenced by other variables, like increased patient demand and low turnaround time of these tests.
Market Segmentation:
Segmentation 1: by Disease Type
• Gastroenterology Disease
• Endocrine and Metabolism Disease
• Cardiovascular Disease
• Neurology Disease
• Hematology and Oncology Disease
• Dermatology Disease
• Other Diseases
Segmentation 2: by Technology
• Sanger Sequencing
• PCR
• NGS
• Microarrays
• Others (Targeted Cytogenetics, Karyotyping, and FISH)
Segmentation 3: by Country
• Japan
• India
• China
• South Korea
• Australia
• Singapore
• Rest-of-Asia-Pacific
Asia-Pacific Rare Disease Genetic Testing Market
Analysis and Forecast, 2023-2033
Similar Product
You may also like